Loteprednol (formulated as the ester loteprednol etabonate) is a topical corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax and Loterex.
Loteprednol (formulated as the ester loteprednol etabonate) is a topical corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax and Loterex.
It was patented in 1980 and approved for medical use in 1998. It is available as a generic medication.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).